Tender Details

Country: Belgium
Summary: Speed up the Access to and Uptake of an Mpox Vaccine
BET Ref No: 116141926
Deadline: 21 Apr 2025
Financier: Other Funding Agencies
Purchaser Ownership: Government
Tender Value: EUR 4900000
Notice Type: Tender
Document Ref. No.: 163055-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The objective of this call for tender is to strengthen the scientific evidence on the immune response provided by the Modified Vaccinia Ankara virus-Bavarian Nordic (MVA-BN) vaccine, with particular emphasis on the need and optimal timing of booster doses. Therefore, the purpose of this call for tenders is to purchase clinical services for clinical research and/or other equivalent scientific activities to evaluate and compare the immunogenicity of a booster dose of MVA-BN vaccine considering different routes of administration, namely intradermal and subcutaneous injection, and the appropriate timing of the booster dose. The activities under this call are expected to include a Phase II and/or Phase III clinical trial(s). The results of the clinical trial(s) should be able to contribute to the development and refinement of vaccination strategies to be adopted by public health authorities, as well as, provide further evidence for the European Commission and EU Member States to consider when developing relevant policies, e.g. on stockpiling initiatives, and/or the feasibility of dose-sparing strategies for Mpox vaccination during shortages
Doc Title: Speed up the access to and uptake of an Mpox vaccine
Contract Type: services
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Speed up the Access to and Uptake of an Mpox Vaccine - Belgium Tender

The HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA) , HADEA - HEALTH AND DIGITAL EXECUTIVE AGENCY, a Government sector organization in Belgium, has announced a new tender for Speed up the Access to and Uptake of an Mpox Vaccine. This tender is published on BelgiumTenders under BET Ref No: 116141926 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-21.

The estimated tender value is EUR 4900000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.